Literature DB >> 3972846

Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells.

A J Millis, M Hoyle, E Reich, D M Mann.   

Abstract

In culture, vascular smooth muscle cells grow and form a confluent monolayer of cells. Under appropriate conditions, regions of the monolayer can be induced to draw away from the substrate and form multicellular nodules. The ultrastructure of the cells in the nodules appears to be similar to that of differentiated smooth muscle cells. The process of nodulation is associated with the synthesis of a unique protein whose molecular weight is estimated from gradient gel electrophoresis to be 38,000 (38-kDa Protein). The protein is secreted into the culture medium and can be detected either by metabolic labeling or by staining with Coomassie Blue. Partial purification of 38-kDa Protein was achieved using affinity chromatography. The protein is adsorbed to heparin-agarose, but not to gelatin-agarose. The concentration of 38-kDa Protein in nodular conditioned medium is estimated at 1.9 micrograms/ml and less than 0.01 microgram/ml in conditioned medium made from monolayer cells. The presence of 5% fetal bovine serum in the labeling medium does not affect 38-kDa Protein synthesis. Cross-reactivity with fibronectin was evaluated using polyvalent antibodies to 38-kDa Protein. The 38-kDa Protein is not antigenically related to fibronectin. Furthermore, we establish that the protein is not qualitatively influenced by the presence of ascorbate (50 micrograms/ml), beta-aminoproprionitrile fumarate (50 micrograms/ml) heparin (10 ng/ml), or fibronectin (20 micrograms/ml) in the culture medium. We find that the added components neither suppress 38-kDa Protein synthesis in nodular cultures nor enhance 38-kDa Protein synthesis in monolayer cultures. The 38-kDa Protein is not detected in either monolayer or nodular cell layers and appears to be a secreted protein. Its appearance in nodular conditioned medium during nodulation suggests a relationship with that process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation.

Authors:  W Lankes; A Griesmacher; J Grünwald; R Schwartz-Albiez; R Keller
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

2.  High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.

Authors:  J S Johansen; A N Pedersen; M Schroll; T Jørgensen; B K Pedersen; H Bruunsgaard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

3.  Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures.

Authors:  R A Majack
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

4.  YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease.

Authors:  Gerit Holger Schernthaner; Clemens Höbaus; Johanna Brix
Journal:  Anatol J Cardiol       Date:  2016-12       Impact factor: 1.596

Review 5.  YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

Authors:  Camilla N Rathcke; Henrik Vestergaard
Journal:  Cardiovasc Diabetol       Date:  2009-11-23       Impact factor: 9.951

6.  Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection.

Authors:  Yina Wu; Zhen Tao; Chao Song; Qingshuai Jia; Jun Bai; Kangkang Zhi; Lefeng Qu
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

7.  YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Authors:  Nicolai A Schultz; Julia S Johansen
Journal:  Cancers (Basel)       Date:  2010-07-12       Impact factor: 6.639

Review 8.  Chitinase-3 like-protein-1 function and its role in diseases.

Authors:  Ting Zhao; Zhongping Su; Yingchang Li; Xiaoren Zhang; Qiang You
Journal:  Signal Transduct Target Ther       Date:  2020-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.